Nevro Corp
(NVRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 88,610 | 109,731 | 108,460 | 56,390 | 87,467 |
| Cost of Goods | 26,316 | 31,703 | 32,383 | 21,140 | 26,920 |
| Gross Profit | 62,294 | 78,028 | 76,077 | 35,250 | 60,547 |
| Operating Expenses | 85,122 | 79,606 | 80,009 | 70,751 | 84,534 |
| Operating Income | -22,512 | -875 | -3,549 | -35,361 | -23,067 |
| Interest Expense | 6,547 | 6,495 | 6,363 | 6,122 | 2,826 |
| Other Income | -160 | 551 | 135 | 464 | 1,311 |
| Pre-tax Income | -29,219 | -6,819 | -9,777 | -41,019 | -24,582 |
| Income Tax | 342 | 310 | 208 | 44 | 306 |
| Net Income Continuous | -29,561 | -7,129 | -9,985 | -41,063 | -24,888 |
| Net Income | $-29,561 | $-7,129 | $-9,985 | $-41,063 | $-24,888 |
| EPS Basic Total Ops | -0.85 | -0.19 | -0.29 | -1.21 | -0.78 |
| EPS Basic Continuous Ops | -0.85 | -0.19 | -0.29 | -1.21 | -0.78 |
| EPS Diluted Total Ops | -0.85 | -0.19 | -0.29 | -1.21 | -0.78 |
| EPS Diluted Continuous Ops | -0.85 | -0.19 | -0.29 | -1.21 | -0.78 |
| EBITDA(a) | $-15,603 | $5,762 | $2,955 | $-27,051 | $-21,066 |